首頁 > 市場調查報告書 > 醫療設備

運輸/物流生技設備

市場調查報告書

商品編碼

1956184

日本醫藥低溫運輸物流市場規模、佔有率、趨勢及預測（依產品、服務及地區分類，2026-2034年）

Japan Cold Chain Pharmaceutical Logistics Market Size, Share, Trends and Forecast by Product, Service, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 142 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本醫藥低溫運輸物流市場規模達9.432億美元。 IMARC Group預測，到2034年，該市場規模將達到21.933億美元，2026年至2034年的複合年成長率（CAGR）為9.83%。日本製藥公司生產種類繁多的溫控藥品，包括尖端生物製藥和疫苗，因此可靠的低溫運輸物流對於確保這些藥品的療效和安全性至關重要。此外，物聯網（IoT）的日益普及也推動了日本醫藥低溫運輸物流市場佔有率的擴大。

日本醫藥低溫運輸物流市場的發展趨勢：

藥品需求不斷成長

藥品需求的成長正對國內市場產生正面影響。隨著人口老化和醫療意識的提高，越來越多的人需要嚴格控制溫度的藥物、疫苗和生物製藥。根據日本政府預測，到2024年，65歲及以上人口將佔總人口的約30%。日本製藥公司生產種類繁多的對溫度敏感的藥品，包括創新型生物製藥和疫苗，而可靠的低溫運輸物流對於維持這些藥品的療效和安全性至關重要。這些產品需求的不斷成長推動了對先進冷藏設施、冷藏運輸和監控系統的需求，以確保整個供應鏈的溫度控制。醫院、藥局和診所仍然高度依賴冷鏈物流來防止藥品品質劣化。此外，日本政府的法規和品質標準要求嚴格遵守藥品儲存和運輸規範，這使得物流公司能夠投資更先進的技術和基礎設施。藥品進出口的成長也推動了市場發展，使得持續穩定的冷鏈管理對於國際運輸至關重要。

物聯網的日益普及

物聯網的日益普及正在推動日本醫藥低溫運輸物流市場的成長。根據IMARC Group預測，到2024年，日本物聯網市場規模預計將達到604.776億美元。物聯網技術能夠即時監控藥品儲存和運輸過程中的溫度、濕度和位置，確保藥品和疫苗保持在指定的溫度範圍內，防止劣化並保持其品質。一旦條件出現偏差，物聯網設備會即時發出警報，以便及時採取糾正措施。這降低了產品損失的風險，並確保符合日本嚴格的監管標準。物聯網還能提供準確的庫存數量和有效期限資訊，從而改善庫存管理。物流公司正在利用物聯網最佳化配送路線和時間安排，減少延誤和成本。物聯網的整合還提高了透明度和可追溯性，有助於在製藥公司、醫療機構和患者之間建立信任。總而言之，物聯網的日益普及滿足了對安全及時交付溫控醫療產品日益成長的需求，提高了日本醫藥低溫運輸物流的可靠性和效率。

本報告解答的關鍵問題

日本醫藥低溫運輸物流市場目前發展狀況如何？未來幾年又將如何發展？
日本藥品低溫運輸物流市場依產品分類的組成是怎樣的？
日本醫藥低溫運輸物流市場依服務類型分類的組成是怎樣的？
日本醫藥低溫運輸物流市場按地區分類的市場組成是怎樣的？
日本醫藥低溫運輸物流市場價值鏈的不同階段有哪些？
日本醫藥低溫運輸物流市場的主要促進因素與挑戰是什麼？
日本醫藥低溫運輸物流市場的結構是怎麼樣的？主要參與者有哪些？
日本醫藥低溫運輸物流市場競爭程度如何？

The Japan cold chain pharmaceutical logistics market size reached USD 943.2 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 2,193.3 Million by 2034, exhibiting a growth rate (CAGR) of 9.83% during 2026-2034. Pharmaceutical firms, based in Japan, are manufacturing a diverse range of temperature-sensitive medications, including cutting-edge biologics and vaccines, that necessitate dependable cold chain logistics to ensure their effectiveness and safety. Besides this, the rising utilization of the Internet of Things (IoT) is contributing to the expansion of the Japan cold chain pharmaceutical logistics market share.

JAPAN COLD CHAIN PHARMACEUTICAL LOGISTICS MARKET TRENDS:

Increasing demand for pharmaceutical products

Rising demand for pharmaceutical products is positively influencing the market in the country. As the population is aging and healthcare awareness is increasing, more people require medicines, vaccines, and biologics that need strict temperature control. As per the Japanese government authorities, individuals aged 65 and older in Japan represented almost 30% of the population in 2024. Pharmaceutical companies in Japan are producing a wide assortment of temperature-sensitive drugs, including innovative biologics and vaccines, which require reliable cold chain logistics to maintain their efficacy and safety. The increasing volume of these items is leading to higher demand for advanced cold storage facilities, refrigerated transportation, and monitoring systems that ensure proper temperature management throughout the supply chain. Hospitals, pharmacies, and clinics continue to rely heavily on cold chain logistics to receive medicines without degradation. Furthermore, government regulations and quality standards in Japan require stringent compliance in pharmaceutical storage and transport, which is enabling logistics providers to invest in better technology and infrastructure. The rise in export and import of pharmaceutical products is also stimulating the growth of the market, as international shipments demand consistent cold chain management.

Growing utilization of IoT

Rising use of the IoT is impelling the Japan cold chain pharmaceutical logistics market growth. According to the IMARC Group, the Japan IoT market size reached USD 60,477.6 Million in 2024. IoT technology allows real-time monitoring of temperature, humidity, and location of pharmaceutical products during storage and transportation. This ensures that medicines and vaccines remain within the required temperature range, preventing spoilage and maintaining their quality. IoT devices send instant alerts if there is any deviation in conditions, allowing quick corrective actions. This reduces the risk of product loss and ensures compliance with strict regulatory standards in Japan. Additionally, IoT improves inventory management by offering precise information on stock quantities and expiration dates. Logistics companies are using IoT to optimize routes and delivery schedules, reducing delays and costs. The integration of IoT also increases transparency and traceability, building trust among pharmaceutical companies, healthcare providers, and patients. Overall, rising IoT adoption enhances the reliability and effectiveness of cold chain pharmaceutical logistics in Japan, supporting the growing demand for safe and timely delivery of temperature-sensitive medical products.

JAPAN COLD CHAIN PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION:

Product Insights:

Vaccines
Biopharmaceuticals
Clinical Trial Materials

Service Insights:

Warehousing and VAS
Transportation

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan cold chain pharmaceutical logistics market performed so far and how will it perform in the coming years?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of product?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of service?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of region?
What are the various stages in the value chain of the Japan cold chain pharmaceutical logistics market?
What are the key driving factors and challenges in the Japan cold chain pharmaceutical logistics market?
What is the structure of the Japan cold chain pharmaceutical logistics market and who are the key players?
What is the degree of competition in the Japan cold chain pharmaceutical logistics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cold Chain Pharmaceutical Logistics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cold Chain Pharmaceutical Logistics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Product

6.1 Vaccines
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Biopharmaceuticals
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Clinical Trial Materials
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Service

7.1 Warehousing and VAS
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Transportation
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Product
- 8.1.4 Market Breakup by Service
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Product
- 8.2.4 Market Breakup by Service
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Product
- 8.3.4 Market Breakup by Service
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Product
- 8.4.4 Market Breakup by Service
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Product
- 8.5.4 Market Breakup by Service
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Product
- 8.6.4 Market Breakup by Service
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Product
- 8.7.4 Market Breakup by Service
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Product
- 8.8.4 Market Breakup by Service
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Cold Chain Pharmaceutical Logistics Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Services Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Services Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Services Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Services Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Services Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Cold Chain Pharmaceutical Logistics Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis